Growth Metrics

Merck (MRK) Total Liabilities (2016 - 2026)

Merck has reported Total Liabilities over the past 18 years, most recently at $82.8 billion for Q1 2026.

  • Quarterly Total Liabilities rose 24.03% to $82.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $82.8 billion through Mar 2026, up 24.03% year-over-year, with the annual reading at $84.3 billion for FY2025, 84160.0% up from the prior year.
  • Total Liabilities was $82.8 billion for Q1 2026 at Merck, down from $84.3 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $84.3 billion in Q4 2025 and troughed at $100.0 million in Q4 2024.
  • The 5-year median for Total Liabilities is $63.8 billion (2022), against an average of $42.1 billion.
  • Year-over-year, Total Liabilities plummeted 99.6% in 2023 and then skyrocketed 84160.0% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $600.0 million in 2022, then tumbled by 58.33% to $250.0 million in 2023, then plummeted by 60.0% to $100.0 million in 2024, then skyrocketed by 84160.0% to $84.3 billion in 2025, then fell by 1.79% to $82.8 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Total Liabilities are $82.8 billion (Q1 2026), $84.3 billion (Q4 2025), and $77.6 billion (Q3 2025).